Skye Bioscience, Inc.

Skye Bioscience, Inc.verified

SKYE

Price:

$1.21

Market Cap:

$38.77M

Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is headquartered in San Diego, California.

Industry

Biotechnology

IPO Date

2014-11-26

Stock Exchange

NASDAQ

Ticker

SKYE

The Current Ratio as of December 2025 (TTM) for Skye Bioscience, Inc. (SKYE) is 6.09

According to Skye Bioscience, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.09. This represents a change of -49.75% compared to the average of 12.11 of the last 4 quarters.

Skye Bioscience, Inc. (SKYE) Historical Current Ratio (quarterly & annually)

How has SKYE Current Ratio performed in the past?

The mean historical Current Ratio of Skye Bioscience, Inc. over the last ten years is 3.30. The current 6.09 Current Ratio has changed 18.36% with respect to the historical average. Over the past ten years (40 quarters), SKYE's Current Ratio was at its highest in in the December 2024 quarter at 16.32. The Current Ratio was at its lowest in in the September 2018 quarter at 0.10.

Quarterly (TTM)
Annual

Average

3.30

Median

1.45

Minimum

0.12

Maximum

16.32

Skye Bioscience, Inc. (SKYE) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Skye Bioscience, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.85%

Maximum Annual Current Ratio = 16.32

Minimum Annual Increase = -92.89%

Minimum Annual Current Ratio = 0.12

Quarterly (TTM)
Annual
YearCurrent RatioChange
202416.321.85%
20230.8413.57%
20220.74-69.96%
20212.46-27.41%
20203.3864.73%
20192.051.58%
20180.12-82.23%
20170.6963.33%
20160.42-92.89%
20155.941.44%

Skye Bioscience, Inc. (SKYE) Average Current Ratio

How has SKYE Current Ratio performed in the past?

The current Current Ratio of Skye Bioscience, Inc. (SKYE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.97

5-year avg

4.75

10-year avg

3.30

Skye Bioscience, Inc. (SKYE) Current Ratio vs. Peers

How is SKYE’s Current Ratio compared to its peers?

Skye Bioscience, Inc.’s Current Ratio is greater than Aligos Therapeutics, Inc. (4.70), greater than Xilio Therapeutics, Inc. (2.20), greater than Mersana Therapeutics, Inc. (1.39), greater than INmune Bio, Inc. (4.17), greater than X4 Pharmaceuticals, Inc. (3.19), less than Kezar Life Sciences, Inc. (7.29), less than Barinthus Biotherapeutics plc (8.04), less than LAVA Therapeutics N.V. (10.78), greater than PDS Biotechnology Corporation (2.09), greater than CEL-SCI Corporation (0.47),

Build a custom stock screener for Skye Bioscience, Inc. (SKYE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Skye Bioscience, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Skye Bioscience, Inc. (SKYE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Skye Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Skye Bioscience, Inc.'s Current Ratio?

How is the Current Ratio calculated for Skye Bioscience, Inc. (SKYE)?

What is the highest Current Ratio for Skye Bioscience, Inc. (SKYE)?

What is the 3-year average Current Ratio for Skye Bioscience, Inc. (SKYE)?

What is the 5-year average Current Ratio for Skye Bioscience, Inc. (SKYE)?

How does the current Current Ratio for Skye Bioscience, Inc. (SKYE) compare to its historical average?